Is machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images associated with outcomes of immunotherapy in patients with NSCLC?

Journal of Thoracic Disease

article

Kentaro Inamura¹  Yasuyuki Shigematsu¹ 

[1] Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research;Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research

关键词: Artificial intelligence;    digital pathology;    immune checkpoint inhibitor (ICI);    non-small cell lung cancer (NSCLC);    tumor microenvironment;   

DOI  :  10.21037/jtd-22-1862

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 摘 要 】

Recent advances in artificial intelligence and slide scanning technology have enabled big data analysis of pathology tissue images. We read with great interest the article by Rakaee and colleagues (1), who developed a machine learning (ML)-based method to count tumor-infiltrating lymphocytes (TILs) on hematoxylin-eosin-stained standard pathologic images of primary or metastatic tumors. The authors demonstrated an association between TIL status based on ML-based assessment and outcomes of immune checkpoint inhibitor (ICI) therapy in patients with non-small cell lung cancer (NSCLC). Specifically, in retrospective cohorts of patients with NSCLC who underwent anti-programmed death-ligand 1 (PD-L1) or anti-programmed death-1 (PD-1) (i.e., anti-CD274 or antiPDCD1) monotherapy, high-TIL (≥250 cells/mm2 ) tumors were associated with more prolonged survival as compared with low-TIL (<250 cells/mm2 ) tumors.

【 授权许可】

Unknown